| 1. |
2024
Hao-Chien Hung,Tsui-Lien Mao,Ming-Huei Fan,Guan-Zhi Huang,Ainani Priza Minhalina,Chi-Long Chen, Chao-Lien Liu.
Enhancement of Tumorigenicity, Spheroid Niche, and Drug Resistance of Pancreatic Cancer Cells in Three-Dimensional Culture System
. Journal of Cancer
.2024
;(15):2292-2305
|
|
| 2. |
2024
Dito Anurogo,Chao-Lien Liu,Yu-Chu Chang,Yu-Hsiang Chang,J. Timothy Qiu.
Discovery of differentially expressed proteins for CAR-T therapy of ovarian cancers with a bioinformatics analysis
. Aging
.2024
;(16)
|
|
| 3. |
2023
Hao-Chien Hung,Ming-Huei Fan,Daniel Wang,Carol H. Miao,Pong Su,Chao Lien Liu.
Effect of chimeric antigen receptor T cells against protease-activated receptor 1 for treating pancreatic cancer
. BMC Medicine
.2023
;(21):338
|
|
| 4. |
2021
Chao Lien Liu,Ray-Hwang Yuan,Tsui-Lien Mao.
The Molecular Landscape Influencing Prognoses of Epithelial Ovarian Cancer
. biomolecules
.2021
;(11)
|
|
| 5. |
2021
Tsui-Lien Mao,Ming-Huei Fan,Nhlanhla Dlamini,Chao-Lien Liu.
LncRNA MALAT1 Facilitates Ovarian Cancer Progression through Promoting Chemoresistance and Invasiveness in the Tumor Microenvironment
. International Journal of Molecular Sciences
.2021
;(22)
|
|
| 6. |
2020
Yuan-Hsi Wang,Fat-Moon Suk,Chao Lien Liu,Tzu-Lang Chen,Yuh-Ching Twu,Ming-Hua Hsu, Yi-Jen Liao.
Antifibrotic Effects of a Barbituric Acid Derivative on Liver Fibrosis by Blocking the NF-kB Signaling Pathway in Hepatic Stellate Cells
. Frontiers in Pharmacology
.2020
;(11)
|
|
| 7. |
2020
Ching-Yao Yang,Ming Huei Fan,Carol H. Miao,Yi Jen Liao,Ray-Hwang Yuan,Chao Lien Liu.
Engineering Chimeric Antigen Receptor T Cells against Immune Checkpoint Inhibitors PD-1/PD-L1 for Treating Pancreatic Cancer
. Molecular Therapy: Oncolytics
.2020
;(17):571-585
|
|
| 8. |
2020
Yi-Jen Liao ,Yuan-Hsi Wang,Chao Lien Liu ,Cheng-Chieh Fang,Ming-Hua Hsu,Fat-Moon Suk.
4-Methoxy Sulfonyl Paeonol Inhibits Hepatic Stellate Cell Activation and Liver Fibrosis by Blocking the TGF-
. Applied Sciences
.2020
;(10):5941
|
|
| 9. |
2020
Chao Lien Liu,Ying Jen Chen,Ming Huei Fan,Yi Jen Liao,Tsui Lien Mao.
Characteristics of CD133-Sustained Chemoresistant Cancer Stem-Like Cells in Human Ovarian Carcinoma
. International Journal of Molecular Sciences
.2020
;(21):6467
|
|
| 10. |
2020
Fu RY,Chen AC,Lyle MJ,Chen CY,Liu CL,Miao CH.
CD4+T cells engineered with FVIII-CAR and murine Foxp3 suppress anti-factor VIII immune responses in hemophilia a mice
. Cellular Immunology
.2020
;(358):104216
|
|
| 11. |
2020
Chen YJ, ,Liao YJ,,Tram VTN,,Lin CH,, Liao KC,,Liu CL.
Alterations of Specific Lymphocytic Subsets with Aging and Age-Related Metabolic and Cardiovascular Diseases
. Life
.2020
;(10):246
|
|
| 12. |
2019
Chao Lien Liu,Jim Jinn-Chyuan Sheu,Hsuan Ping Lin,Yung Ming Jeng,Cherry Yin Yi Chang,Chih Mei Chen, Jack Cheng, Tsui Lien Mao.
The overexpression of MYST4 in human solid tumor is associated with increased aggressiveness and decreased overall survival
. International Journal of Clinical and Experimental Pathology
.2019
;(12):431-442
|
|
| 13. |
2019
Tsui Lien Mao,Carol H. Miao,Yi Jen Liao,Ying Jen Chen,Chia Yu Yeh,Chao Lien Liu.
Ex Vivo Expanded Human Vr9Vd2 T-Cells Can Suppress Epithelial Ovarian Cancer Cell Growth
. International Journal of Molecular Sciences
.2019
;(20):1139
|
|
| 14. |
2019
Chao Lien Liu,Hung Wei Pan,Pao Ling Torng,Ming Huei Fan,Tsui Lien Mao.
SRPX and HMCN1 regulate cancer-associated fibroblasts to promote the invasiveness of ovarian carcinoma.
. Oncology Reports
.2019
;(42):2706-2715
|
|
| 15. |
2019
Fat-Moon Suk*, Chao Lien Liu*,Ming-Hua Hsu,Yu-Ting Chuang,Jack P. Wang,Yi-Jen Liao.
Treatment with a new benzimidazole derivative bearing a pyrrolidine side chain overcomes sorafenib resistance in hepatocellular carcinoma
. Scientific Reports
.2019
;(9):17259
|
|
| 16. |
2019
Yuan-Hsi Wang,Chao Lien Liu,Wan-Chun Chiu,Yuh-Ching Two,Yi-Jen Liao.
HMGCS2 Mediates Ketone Production and Regulates the Proliferation and Metastasis of Hepatocellular Carcinoma
. Cancers
.2019
;(11):1876
|
|
| 17. |
2017
Mao T. L. ,Fan K. F. ,Liu C. L. .
Targeting the CXCR4/CXCL12 axis in treating epithelial ovarian cancer
. Gene Therapy
.2017
;(24):621-629
|
|
| 18. |
2016
Chao Lien Liu,Meghan J. Lyle,Simon C. Shin,Carol H. Miao.
Strategies to target long-lived plasma cells for treating hemophilia A inhibitors
. Cellular Immunology
.2016
;(301):65-73
|
|
| 19. |
2016
Chao Lien Liu,Meghan J. Lyle,Simon C. Shin,Carol H. Miao.
The dataset from administration of single or combined immunomodulation agents to modulate anti-FVIII antibody responses in FVIII plasmid or protein primed hemophilia A mice
. Data in Brief
.2016
;(7):973-980
|
|
| 20. |
2014
Chao Lien Liu,Peiqing Ye,Jacqueline Lin,Che'rie L. Butts,Carol H. Miao.
Anti-CD20 as the B cell targeting agent in a combined therapy to modulate anti-factor VIII responses in hemophilia A inhibitor mice
. Frontiers in Immunology
.2014
;(4):1-8
|
|
| 21. |
2014
Chao lien Liu,Peiqing Ye,Jacqueline Lin,Carol H. Miao.
Long-term tolerance to factor VIII is achieved by administration of IL-2/IL-2mAb complexes and low dosages of factor VIII
. J. Thrombosis Haemostasis
.2014
;(12):921-931
|
|
| 22. |
2011
Chao Lien Liu,Peiqing Ye,Benjamin C. Yen,Carol H. Miao.
In vivo expansion of regulatory T cells with IL-2/IL-2 mAb complexes privets anti-factor VIII immune responses in hemophilia A mice treated with factor VIII plasmid-mediated gene therapy
. Molecular Therapy
.2011
;(19):1511-1520
|
|
| 23. |
2007
Liu CL,Yu IS,Pan HW,Lin SW,Hsu HC.
L2dtl is essential for cell survival and nuclear division in early mouse embryonic development
. J. Biol. Chem.
.2007
;(282):1109-1118
|
|
| 24. |
2006
Pan HW,Chou HY,Liu SH,Peng SY,Liu CL,Hsu HC.
Role of L2DTL, Cell Cycle-Regulated Nuclear and Centrosome Protein, in Aggressive Hepatocellular Carcinoma
. Cell Cycle
.2006
;(5):2676-2687
|
|
| 25. |
2002
Liu SH,Lin CY,Peng SY,Jeng YM,Pan HW,Lai PL, Liu CL, Hsu HC.
Down-regulation of annexing A10 in hepatocellular carcinoma is associated with vascular invasion, early recurrence, and poor prognosis in synergy with p53 mutation
. Am J Pathol
.2002
;(160):1831-1837
|
|